Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PHATHOM PHARMACEUTICALS INC.
PHAT | US
12.16
USD0.43
3.67%
PHAT | US
About PHATHOM PHARMACEUTICALS INC.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
23/04/2026
Close
12.16
Open
11.58
High
12.17
Low
11.43
Phathom Pharmaceuticals Inc. biopharmaceutical company focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States Europe and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals Inc. was incorporated in 2018 and is headquartered in Florham Park New Jersey.
View LessPHAT | US
Risk
57.9
Sharpe
1.66
Luna's Score
54/100
Recommendation
Hold
Luna says (PHAT | US)
What's Working
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
High Short-term Volatility
Smallcap (300M - 2B USD)
High Short percentage (> 15%)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
69.0%1 month
57.9%3 months
63.1%6 months
60.8%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
25.37
Debt to equity
-2.17
Debt to assets
1.59
Ent. to EBITDA
-2.20
Ent. to rev.
101.64
PEG
-
Other Fundamentals
EBITDA
-252.07M
MarketCap
830.40M
MarketCap(USD)
830.40M
Div. yield
-
Op. margin
-1.06K
Erngs. growth
-
Rev. growth
-
Ret. on equity
-3.49K
Short ratio
15.37
Short perc.
35.61
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
2.23
Range1M
3.67
Range3M
4.67
Volumes: Market Activity
Rel. volume
1.16
Price X volume
15.12M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.20 | - | Cheaper |
| Ent. to Revenue | 101.64 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 25.37 | 15.55 | Expensive |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 63.08 | - | Par |
| Debt to Equity | -2.17 | -1.23 | Cheaper |
| Debt to Assets | 1.59 | 0.25 | Expensive |
| Market Cap | 830.40M | - | Emerging |
